401 related articles for article (PubMed ID: 29610531)
1. Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells.
Ma X; Chen X; Jin Y; Ge W; Wang W; Kong L; Ji J; Guo X; Huang J; Feng XH; Fu J; Zhu S
Nat Commun; 2018 Apr; 9(1):1303. PubMed ID: 29610531
[TBL] [Abstract][Full Text] [Related]
2. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
Zhu Z; González F; Huangfu D
Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3'-overhang.
Bin Moon S; Lee JM; Kang JG; Lee NE; Ha DI; Kim DY; Kim SH; Yoo K; Kim D; Ko JH; Kim YS
Nat Commun; 2018 Sep; 9(1):3651. PubMed ID: 30194297
[TBL] [Abstract][Full Text] [Related]
4. [CRISPR/Cas system for genome editing in pluripotent stem cells].
Vasil'eva EA; Melino D; Barlev NA
Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cpf1-mediated genome editing and gene regulation in human cells.
Li T; Zhu L; Xiao B; Gong Z; Liao Q; Guo J
Biotechnol Adv; 2019; 37(1):21-27. PubMed ID: 30399413
[TBL] [Abstract][Full Text] [Related]
6. Efficient scarless genome editing in human pluripotent stem cells.
Ikeda K; Uchida N; Nishimura T; White J; Martin RM; Nakauchi H; Sebastiano V; Weinberg KI; Porteus MH
Nat Methods; 2018 Dec; 15(12):1045-1047. PubMed ID: 30504872
[TBL] [Abstract][Full Text] [Related]
7. Genome Editing in Human Pluripotent Stem Cells.
Carlson-Stevermer J; Saha K
Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
[TBL] [Abstract][Full Text] [Related]
8. Design and assessment of engineered CRISPR-Cpf1 and its use for genome editing.
Li B; Zeng C; Dong Y
Nat Protoc; 2018 May; 13(5):899-914. PubMed ID: 29622802
[TBL] [Abstract][Full Text] [Related]
9. Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells.
Riesenberg S; Maricic T
Nat Commun; 2018 Jun; 9(1):2164. PubMed ID: 29867139
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum.
Jiang Y; Qian F; Yang J; Liu Y; Dong F; Xu C; Sun B; Chen B; Xu X; Li Y; Wang R; Yang S
Nat Commun; 2017 May; 8():15179. PubMed ID: 28469274
[TBL] [Abstract][Full Text] [Related]
11. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
Yang F; Li Y
Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
[TBL] [Abstract][Full Text] [Related]
12. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting.
Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
Nat Commun; 2017 Apr; 8():14958. PubMed ID: 28387220
[TBL] [Abstract][Full Text] [Related]
13. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
15. The Conspicuity of CRISPR-Cpf1 System as a Significant Breakthrough in Genome Editing.
Bayat H; Modarressi MH; Rahimpour A
Curr Microbiol; 2018 Jan; 75(1):107-115. PubMed ID: 29189942
[TBL] [Abstract][Full Text] [Related]
16. Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo.
Park HM; Liu H; Wu J; Chong A; Mackley V; Fellmann C; Rao A; Jiang F; Chu H; Murthy N; Lee K
Nat Commun; 2018 Aug; 9(1):3313. PubMed ID: 30120228
[TBL] [Abstract][Full Text] [Related]
17. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.
Hou Z; Zhang Y; Propson NE; Howden SE; Chu LF; Sontheimer EJ; Thomson JA
Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15644-9. PubMed ID: 23940360
[TBL] [Abstract][Full Text] [Related]
18. Small molecules enhance CRISPR genome editing in pluripotent stem cells.
Yu C; Liu Y; Ma T; Liu K; Xu S; Zhang Y; Liu H; La Russa M; Xie M; Ding S; Qi LS
Cell Stem Cell; 2015 Feb; 16(2):142-7. PubMed ID: 25658371
[TBL] [Abstract][Full Text] [Related]
19. An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells.
Xie Y; Wang D; Lan F; Wei G; Ni T; Chai R; Liu D; Hu S; Li M; Li D; Wang H; Wang Y
Sci Rep; 2017 May; 7(1):2320. PubMed ID: 28539611
[TBL] [Abstract][Full Text] [Related]
20. Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing.
Li B; Zeng C; Li W; Zhang X; Luo X; Zhao W; Zhang C; Dong Y
Cell Rep; 2018 Dec; 25(12):3262-3272.e3. PubMed ID: 30566855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
